Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T de Witte

Showing results (71-80 of 264) with videos related to

Pageof 27
Sort By:
Leukemia|November 21, 1998
In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fractionS Wittebol, R Raymakers, L van de Locht, et al.
Bone Marrow Transplantation|January 1, 1993
Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugationT De Witte, A Schattenberg, F Preijers, et al.
Vox Sanguinis|January 1, 1985
Concentration of hematopoietic progenitor cells from human bone marrow by a new type of blood component separatorC G Figdor, T de Witte, R Raymakers, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 12, 1986
[Prevention of graft-vs-host disease following allogeneic bone marrow transplantation]T de Witte, J Janssen, B de Pauw, et al.
Lancet (London, England)|October 17, 1987
Itraconazole and cyclosporin nephrotoxicityI Nováková, P Donnelly, T de Witte, et al.
Leukemia & Lymphoma|January 29, 2011
Comparison of chimerism of red cells with that of granulocytes, T-lymphocytes, and bone marrow cells in recipients of bone marrow grafts depleted of lymphocytes using counterflow centrifugationA Schattenberg, B Bär, J Vet, et al.
Cancer|April 1, 1984
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's diseaseT de Witte, H A Blacklock, H G Prentice, et al.
International Journal of Cancer|November 4, 1996
Highly potent CD22-recombinant ricin A results in complete cure of disseminated malignant B-cell xenografts in SCID mice but fails to cure solid xenografts in nude miceP J Van Horssen, F W Preijers, Y V Van Oosterhout, et al.
Lancet (London, England)|May 2, 1992
Fever in neutropenic patients treated with GM-CSF representing enhanced host defenceG Vreugdenhil, F Preyers, S Croockewit, et al.
Scandinavian Journal of Immunology|June 1, 1995
Cytotoxic potency of CD22-ricin A depends on intracellular routing rather than on the number of internalized moleculesP J van Horssen, Y V van Oosterhout, T de Witte, et al.
Pageof 27

Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
Leukemia|November 21, 1998
In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fractionS Wittebol, R Raymakers, L van de Locht, et al.
Bone Marrow Transplantation|January 1, 1993
Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugationT De Witte, A Schattenberg, F Preijers, et al.
Vox Sanguinis|January 1, 1985
Concentration of hematopoietic progenitor cells from human bone marrow by a new type of blood component separatorC G Figdor, T de Witte, R Raymakers, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 12, 1986
[Prevention of graft-vs-host disease following allogeneic bone marrow transplantation]T de Witte, J Janssen, B de Pauw, et al.
Lancet (London, England)|October 17, 1987
Itraconazole and cyclosporin nephrotoxicityI Nováková, P Donnelly, T de Witte, et al.
Leukemia & Lymphoma|January 29, 2011
Comparison of chimerism of red cells with that of granulocytes, T-lymphocytes, and bone marrow cells in recipients of bone marrow grafts depleted of lymphocytes using counterflow centrifugationA Schattenberg, B Bär, J Vet, et al.
Cancer|April 1, 1984
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's diseaseT de Witte, H A Blacklock, H G Prentice, et al.
International Journal of Cancer|November 4, 1996
Highly potent CD22-recombinant ricin A results in complete cure of disseminated malignant B-cell xenografts in SCID mice but fails to cure solid xenografts in nude miceP J Van Horssen, F W Preijers, Y V Van Oosterhout, et al.
Lancet (London, England)|May 2, 1992
Fever in neutropenic patients treated with GM-CSF representing enhanced host defenceG Vreugdenhil, F Preyers, S Croockewit, et al.
Scandinavian Journal of Immunology|June 1, 1995
Cytotoxic potency of CD22-ricin A depends on intracellular routing rather than on the number of internalized moleculesP J van Horssen, Y V van Oosterhout, T de Witte, et al.
Pageof 27